Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03937219 |
|---|---|
| Brief Title: | Study of Cabozantinib in Combination With Nivolumab and Ipilimumab in Patients With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma (COSMIC-313) |
| First Submitted : | May 2, 2019 |
| First Submitted that Met QC Criteria : | May 2, 2019 |
| First Posted : | May 3, 2019 |
| Certification/Extension First Submitted : | January 23, 2023 |
| Certification/Extension First Submitted that Met QC Criteria : | January 23, 2023 |
| Certification/Extension First Posted : | January 26, 2023 |
| Last Update Submitted that Met QC Criteria : | April 11, 2023 |
| Last Update Posted : | April 13, 2023 |